MTC
LLY icon

Matrix Trust Company’s Eli Lilly LLY Stock Holding History

Matrix Trust Company’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.19M Buy
2,656
+512
+24% +$523K 0.46% 29
2026
Q1 		$1.97M Sell
2,144
-61
-3% -$61.8K 0.33% 41
2025
Q4 		$2.37M Buy
2,205
+1,545
+234% +$1.48M 0.39% 32
2025
Q3 		$504K Buy
660
+222
+51% +$165K 0.08% 91
2025
Q2 		$341K Buy
438
+171
+64% +$133K 0.05% 109
2025
Q1 		$221K Buy
267
+55
+26% +$45.8K 0.04% 120
2024
Q4 		$164K Buy
+212
New +$176K 0.03% 113

Other funds holding LLY

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Matrix Trust Company's LLY Position: Q2 2026 in Review

Matrix Trust Company increased its Eli Lilly (LLY) stake by 24% in Q2 2026, buying an estimated $523K and bringing the position to 2,656 shares worth $3.19M. The position accounts for 0.46% of the portfolio, ranked #29.

Matrix Trust Company first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Matrix Trust Company held 2,656 shares of Eli Lilly worth $3.19M as of Q2 2026.
  • Matrix Trust Company bought 512 Eli Lilly shares in Q2 2026, an estimated $523K.
  • Eli Lilly made up 0.46% of Matrix Trust Company's portfolio in Q2 2026, its #29 holding.
  • Matrix Trust Company first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Matrix Trust Company's 13F filing for Q2 2026, filed 9 Jul 2026.